GlassScriptPhysician profile
Farooq A Padder
NPI 1700833449
$3,888.01
in general payments reported to CMS, 2019-2025
25 companies · $832 in 2025
The $832 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,588 · 2020: $145 · 2021: $96.71 · 2022: $312 · 2023: $445 · 2024: $469 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,746.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,431.06 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $637.32 | 2019-2025 | |
| Medtronic, INC. | $362.97 | 2021-2024 | Linq II, Selectsecure |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $202.13 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $191.47 | 2022-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $149.75 | 2019-2024 | Xarelto |
| Pfizer INC. | $109.32 | 2019-2025 | |
| Amgen INC. | $108.02 | 2019-2025 | Repatha, Repatha |
| Stryker Corporation | $99.74 | 2025 | Artix Mt, Flowtriever |
| Abbott Laboratories | $85.05 | 2019-2025 | Triclip, Jot Dx |
| Kestra Medical Technology Services, INC. | $69.71 | 2023 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $68.00 | 2023-2025 | Optimizer, Optimizer |
| Boston Scientific Corporation | $45.04 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor |
| Philips North America LLC | $44.95 | 2023-2024 | (5044) Mcot |
| Kiniksa Pharmaceuticals, LTD. | $44.53 | 2023 | Arcalyst |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $41.75 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.58 | 2025 | Jardiance |
| Atricure, INC. | $30.85 | 2024 | |
| Altathera Pharmaceuticals LLC | $24.58 | 2024 | Sotalol Hydrochloride |
| Inspire Medical Systems, INC. | $23.06 | 2025 | Inspire |
| Abiomed | $20.98 | 2023 | Impella |
| Esperion Therapeutics, INC. | $18.35 | 2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $18.00 | 2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $16.32 | 2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $13.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farooq Padder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.